UNI MEDICAL unveils HK$0.36 final dividend, seeks fresh buy-back & issuance mandates, ups connected-deal cap ahead of 24 June AGM

Bulletin Express06-02

Genertec Universal Medical Group Company Limited (UNI MEDICAL) has released its 2026 Annual General Meeting (AGM) circular, outlining a broad agenda that combines shareholder payouts, refreshed capital mandates and tighter governance measures.

Dividend & Key Dates • 2025 final dividend proposed at HK$0.36 per share. • Shareholders on record as at 3 July 2026 will receive payment on 15 July 2026. • The register closes 30 June–3 July 2026 for dividend entitlement; AGM voting record date is 18–24 June 2026.

Capital Management Proposals • Share Buy-back Mandate: authority to repurchase up to 201.42 million shares (10% of the 2.01 billion shares in issue). • Issue Mandate: authority to allot up to 402.84 million new shares (20% of shares in issue) and to reissue any treasury shares. • Extension Mandate: the issuance limit may increase by the number of shares actually bought back.

Board & Governance • Re-election of five directors: Xia Qi (CEO), Tong Chaoyin, Huang Youjie, Ma Wanming and independent member Li Yinquan (in post since 2015). • SHINEWING (HK) CPA proposed for re-appointment; expected FY-2026 audit fee of RMB4.00 million–RMB4.20 million. • Proposed amendments to the Articles of Association to accommodate Hong Kong’s new treasury-share regime, electronic communications and hybrid/virtual meetings.

Connected Transactions • Medical Related Product Procurement Framework Agreement annual cap for FY-2026 lifted to RMB680.00 million from RMB510.00 million after FY-2025 usage reached RMB547.83 million. • GT-PRC (the state-owned ultimate parent) and its associates will abstain from voting on this item; they control 37.66% of UNI MEDICAL’s share capital.

AGM Logistics • Meeting scheduled for 10:30 a.m., 24 June 2026, Room 1, 10/F, United Centre, Admiralty, Hong Kong. • Proxy forms must reach Computershare Hong Kong by 10:30 a.m., 22 June 2026. • No gifts or refreshments will be provided at the venue.

Shareholders approving all resolutions will authorise the company to execute the new dividend, capital mandates, revised connected-transaction cap and updated Articles, positioning UNI MEDICAL for greater balance-sheet flexibility and enhanced compliance with evolving Hong Kong regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment